EVIDENCE SCIENTIFIC SOLUTIONS LIMITED
Company number 06644159
- Company Overview for EVIDENCE SCIENTIFIC SOLUTIONS LIMITED (06644159)
- Filing history for EVIDENCE SCIENTIFIC SOLUTIONS LIMITED (06644159)
- People for EVIDENCE SCIENTIFIC SOLUTIONS LIMITED (06644159)
- Charges for EVIDENCE SCIENTIFIC SOLUTIONS LIMITED (06644159)
- More for EVIDENCE SCIENTIFIC SOLUTIONS LIMITED (06644159)
| Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
|---|---|---|---|
| 21 Jul 2025 | CS01 | Confirmation statement made on 11 July 2025 with no updates | |
| 28 Feb 2025 | CH01 | Director's details changed for Stanford Benjamin Rudnick on 9 December 2024 | |
| 10 Feb 2025 | AP01 | Appointment of Stanford Benjamin Rudnick as a director on 9 December 2024 | |
| 24 Jan 2025 | TM01 | Termination of appointment of Howard Collins Miller Iii as a director on 31 December 2024 | |
| 24 Jan 2025 | TM01 | Termination of appointment of Joshua Hollis Korth as a director on 15 November 2024 | |
| 29 Oct 2024 | AP01 | Appointment of Mr. Adam Brent Deutsch as a director on 20 August 2024 | |
| 01 Oct 2024 | AA | Audit exemption subsidiary accounts made up to 31 December 2023 | |
| 01 Oct 2024 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/23 | |
| 01 Oct 2024 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/23 | |
| 01 Oct 2024 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/23 | |
| 21 Aug 2024 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/23 | |
| 21 Aug 2024 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/23 | |
| 16 Jul 2024 | CS01 | Confirmation statement made on 11 July 2024 with no updates | |
| 15 Jul 2024 | CH01 | Director's details changed for Joshua Hollis Korth on 14 December 2021 | |
| 12 Jul 2024 | PSC05 | Change of details for Envision Pharma Holdco Limited as a person with significant control on 11 July 2016 | |
| 11 Jul 2024 | PSC05 | Change of details for Envision Pharma Holdco Limited as a person with significant control on 11 July 2016 | |
| 27 Sep 2023 | AP01 | Appointment of Mr Howard Collins Miller Iii as a director on 12 September 2023 | |
| 26 Sep 2023 | TM01 | Termination of appointment of Margaret Heim as a director on 2 August 2023 | |
| 25 Sep 2023 | AA | Audit exemption subsidiary accounts made up to 31 December 2022 | |
| 25 Sep 2023 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/22 | |
| 25 Sep 2023 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/22 | |
| 25 Sep 2023 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/22 | |
| 02 Aug 2023 | CS01 | Confirmation statement made on 11 July 2023 with no updates | |
| 22 Mar 2023 | AP01 | Appointment of Mrs Margaret Heim as a director on 21 February 2023 | |
| 21 Sep 2022 | AA | Audit exemption subsidiary accounts made up to 31 December 2021 |